NCT01967966View on ClinicalTrials.gov

A Bioavailability and Pharmacokinetic Study of GDC-0032 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

Healthy Volunteer

Interventions

DRUG

GDC-0032

Single oral dose

DRUG

GDC-0032

Single IV dose

Trial Locations (1)

53704

Madison

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY